½ÃÀ庸°í¼­
»óǰÄÚµå
1640367

ÀÇ·á ¿µ»ó ¼ÒÇÁÆ®¿þ¾î : ½ÃÀå Á¡À¯À² ºÐ¼®, »ê¾÷ µ¿Çâ ¹× Åë°è, ¼ºÀå ¿¹Ãø(2025-2030³â)

Medical Imaging Software - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Mordor Intelligence | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

ÀÇ·á ¿µ»ó ¼ÒÇÁÆ®¿þ¾î ½ÃÀå ±Ô¸ð´Â 2025³â¿¡ 87¾ï 5,000¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç, ¿¹Ãø ±â°£(2025-2030³â)ÀÇ CAGRÀº 7.84%·Î, 2030³â¿¡´Â 127¾ï 6,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

Medical Imaging Software-Market-IMG1

¸Ó½Å·¯´× ¹× ÀΰøÁö´É°ú °°Àº Çõ½ÅÀûÀÎ ºÐ¼® Àü·«ÀÌ º¸´Ù Á¤È®Çϰí Á¤¹ÐÈ­µÇ¸é¼­ ÀÇ·á »ê¾÷ÀÇ °ü½ÉÀ» ²ø°í ÀÖ½À´Ï´Ù.

ÁÖ¿ä ÇÏÀ̶óÀÌÆ®

  • °üÀý¿°°ú ¾Ï µîÀÇ °íµµÀÇ Ä¡·á¸¦ À§ÇØ ÀÇ·á ¿µ»ó ¼ÒÇÁÆ®¿þ¾î¿¡´Â °íµµÀÇ ±â¼úÀÌ ÇÊ¿äÇÕ´Ï´Ù. °íµµÀÇ ¿µ»ó ±â¼úÀº ȯÀÚÀÇ »óÅ¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ Á¤º¸¸¦ Á¦°øÇÏ¿© ÀÇ»ç ¹× ±âŸ °Ç°­ °ü¸® Àü¹®°¡°¡ ȯÀÚÀÇ Ä¡·á¸¦ ÁøÇàÇÏ°í ¾÷¹« »ý»ê¼ºÀ» Çâ»ó½ÃŰ´Â µ¥ »ç¿ëµË´Ï´Ù.
  • Ä¡°ú, Á¤Çü¿Ü°ú, ¼øÈ¯±â³»°ú, »êºÎÀΰú, À¯¹æ Á¶¿µ¼ú, ºñ´¢±â°ú, ½Å°æ°ú µîÀÇ ÀÀ¿ë ºÐ¾ß¿¡¼­ ¿µ»ó ¼ÒÇÁÆ®¿þ¾î ¼ö¿ä Áõ°¡°¡ ½ÃÀå ¼ºÀå¿¡ ±â¿©ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
  • ƯÈ÷ ¸¸¼º ÁúȯÀÇ Á¶±â Áø´ÜÀ» À§ÇØ ÃÊÀ½ÆÄ ¿µ»ó Áø´Ü ÀåÄ¡ÀÇ »ç¿ëÀÌ Áõ°¡Çϰí ÀÖ´Ù´Â Á¡Àº ½ÃÀå ¼ö¿ä¸¦ °ßÀÎÇϰí ÀÖ´Â °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ¶ÇÇÑ, ÄÄÇ»ÅÍ Áö¿ø Áø´Ü(CAD)°ú °°Àº ¿µ»ó ±â¼úÀÇ Áøº¸µµ ÀÌ·¯ÇÑ ½Ã½ºÅÛ¿¡ ´ëÇÑ ¼ö¿ä¸¦ ³ôÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÇ·á ¿µ»ó Áø´Ü ºÐ¾ßÀÇ ÀΰøÁö´É(AI) ä¿ëÀº ÃÖ±Ù ½ÃÀå µ¿ÇâÀ» ÀϺ¯½Ã۰í ÇâÈÄ ¼ºÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
  • ³ôÀº ¿µ»ó Àåºñ ºñ¿ëÀº ¼ÒÇÁÆ®¿þ¾î µµÀÔ ºñ¿ë°ú ¶óÀ̼±½º ºñ¿ëÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ƯÈ÷ »óȯ °èȹÀÌ ºÎÁ·ÇÑ ±¹°¡¿¡¼­´Â ½ÃÀå È®´ëÀÇ °¡Àå Å« Á¦¾àÀÌ µÇ¾ú½À´Ï´Ù. ¿¹¸¦ µé¾î °³¹ßµµ»ó±¹ÀÇ º´¿ø°ú Áø´Ü¼¾ÅÍ¿Í °°Àº ÀÇ·á ½Ã¼³ÀÇ ´ëºÎºÐÀº ºñ¿ëÀÌ ¸¹ÀÌ µì´Ï´Ù.
  • COVID-19ÀÇ ´ëÀ¯Çà µ¿¾È ´Ù¾çÇÑ AI, ¸Ó½Å·¯´×, µö·¯´× ±â¼úÀÌ ÀÇ·á ¿µ»ó 󸮿¡ ÀÀ¿ëµÇ¾ú°í ÀÌ´Â ½ÃÀå È®´ë¸¦ ´õ¿í ÃËÁøÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ´õ ³ªÀº ȯÀÚ Ä¡·á °á°ú¸¦ À§ÇÑ È¿À²ÀûÀÎ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ô¾ÆÁö°í Àֱ⠶§¹®¿¡ Áø´Ü ¹× ¿¬±¸ ±â°üÀÌ ¿µ»ó ºÐ¼® ¼Ö·ç¼ÇÀÇ Áß¿äÇÑ ÃÖÁ¾ »ç¿ëÀÚ·Î ºÎ»óÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÇ·á ÀÀ¿ë ºÐ¾ßÀÇ ±â¼úÀû Áøº¸·Î ½ÃÀåÀº ÆÒµ¥¹Í ÀÌÈÄ »ó½ÂÇϰí ÀÖ½À´Ï´Ù.

ÀÇ·á ¿µ»ó ¼ÒÇÁÆ®¿þ¾î ½ÃÀå µ¿Çâ

½ÃÀå ¼¼ºÐÈ­ : ½ÉÀ庴 °ü·Ã ¾ÖÇø®ÄÉÀ̼ÇÀÌ ÁÖ¿ä Á¡À¯À²À» Â÷Áö

  • ½ÉÀå°ú °ü·ÃµÈ ¸¸¼º ÁúȯÀÇ ºóµµ°¡ ¼¼°èÀûÀ¸·Î Áõ°¡ÇÔ¿¡ µû¶ó ÀÇ·á ¿µ»ó ¼ÒÇÁÆ®¿þ¾î¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¼ö¿ä°¡ ³ô¾ÆÁü¿¡ µû¶ó ½ÃÀ尳ôÀ» ÁøÇàÇÏ´Â À¯·Â±â¾÷Àº ¿¬±¸°³¹ß°ú ½ÅÁ¦Ç° ÅõÀÔ, ÇÕÀÛ»ç¾÷ ¹× Àμö¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù.
  • ¿¹¸¦ µé¾î, Philips´Â 2022³â 3¿ù ¿µ»ó ó¸® ¾÷°èÀÇ ´Ù¾çÇÑ ¿öÅ©ÇÃ·Î¿ì ¼ö¿ä¸¦ ¼ö¿ëÇϵµ·Ï ¼³°èµÈ ¿ÏÀü ÅëÇÕ Å¬¶ó¿ìµå Áö¿ø ÀÇ·á IT Ç÷§ÆûÀÎ 'Health Suite Interoperability'¸¦ ¹ßÇ¥Çß½À´Ï´Ù.
  • ÀÇ·á ¿µ»ó ¼ÒÇÁÆ®¿þ¾î´Â ºÐ¼® ¼Óµµ¿Í Á¤È®µµ¸¦ Çâ»ó½ÃŰ´Â °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖ½À´Ï´Ù. ¼¼°è ÁÖ¿ä ±â¾÷µéÀº AI¿Í Ŭ¶ó¿ìµå ÄÄÇ»ÆÃ°ú °°Àº ½Å±â¼úÀ» ÅëÇÕÇÏ°í »õ·Î¿î ÀÇ·á ¿µ»ó ¼ÒÇÁÆ®¿þ¾î ¾ÖÇø®ÄÉÀ̼ÇÀ» µµÀÔÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î »÷ÇÁ¶õ½Ã½ºÄÚ¿¡ À§Ä¡ÇÑ Arterys´Â µö·¯´× AI ¾Ë°í¸®Áò°ú Ŭ¶ó¿ìµå ÄÄÇ»ÆÃÀ» °áÇÕÇÏ¿© ½ÉÀå MRI¸¦ À§ÇØ ¼³°èµÇ¾úÀ¸¸ç ½ÉÀåÀÇ ÀÌ»ó º´º¯À» È®ÀÎÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù.
  • 2022³â 2¿ù, Cleery´Â µ¿¸Æ °æÈ­ÀÇ ¾ç°ú À¯Çü¿¡ µû¶ó ½ÉÀ庴À» ÃßÀûÇÏ´Â ¼ÒÇÁÆ®¿þ¾îÀÇ »õ·Î¿î ¹öÀüÀÎ Cleery 2.2.0À» Ãâ½ÃÇß½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀåÀÇ Çõ½Å°ú ½ÅÁ¦Ç° Ãâ½Ã´Â ÀÇ·á ¿µ»ó ¼ÒÇÁÆ®¿þ¾î ½ÃÀå ±Ô¸ð È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.
  • ½ÉÀå À̽İú °°Àº ½ÉÀå Áúº´¿¡¼­ ÀÇ·á ¿µ»ó ¼ÒÇÁÆ®¿þ¾î´Â üÀû ¹× ±â´ÉÀû µ¥ÀÌÅÍ ºÐ¼®À» À§ÇØ »ç¿ëµË´Ï´Ù. Scandiatransplant¿¡ µû¸£¸é 2021³â ºÏÀ¯·´ ±¹°¡ÀÇ ½ÉÀå ÀÌ½Ä È¯ÀÚ ¼ö´Â ½º¿þµ§ÀÌ °¡Àå ¸¹¾ÒÀ¸¸ç 66¸íÀÌ »õ·Î¿î ½ÉÀåÀ» À̽ÄÇß½À´Ï´Ù. µ§¸¶Å©´Â 24¸íÀ¸·Î µÎ ¹øÂ°·Î ÀÌ½Ä È¯ÀÚ ¼ö°¡ ¸¹¾Ò½À´Ï´Ù.

ºÏ¹Ì°¡ ÃÖ´ë ½ÃÀå ±Ô¸ð¸¦ ±â·ÏÇÒ Àü¸Á

  • ºÏ¹Ì´Â ¼¼°è ÃÖ´ëÀÇ ÀÇ·á ¿µ»ó ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀÌ µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ Áö¿ªÀº ƯÈ÷ ¹Ì±¹, ¸ß½ÃÄÚ, ij³ª´Ù µî ±¹°¡¿¡¼­ ÀÇ·á ÀÎÇÁ¶ó¿¡ ´ëÇÑ ÅõÀÚ°¡ »ó´çÈ÷ ³ôÀº ¼öÁØ¿¡ ÀÖ½À´Ï´Ù. ÀÌ ½Ã³ª¸®¿À´Â ÀÌ Áö¿ª¿¡¼­ Çϵå¿þ¾î°¡ Áõ°¡ÇÔ¿¡ µû¶ó ÀÇ·á ¿µ»ó ¼ÒÇÁÆ®¿þ¾î ¼ö¿ä¸¦ ³ôÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
  • ÀÌ Áö¿ª¿¡¼­´Â ÃֽŠÁø´Ü ±â±â¸¦ °®Ãá ÀÇ·á±â°üÀÌ Á¤ºñµÇ¾î ÀÖ´Â Á¡°ú ÀÇ·á ITÀÇ ÀÌ¿ëÀ» ÃËÁøÇÏ´Â Æí¸®ÇÑ Á¤ºÎ ½ÃÃ¥ÀÌ ¼ö¿ä Áõ°¡ÀÇ ¿äÀÎÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ R&D ÅõÀÚ Áõ°¡¿Í °æÀï»çÀÇ Á¸Àç°¡ ÀÌ Áö¿ª ½ÃÀå È®´ë¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù.
  • 2022³â 10¿ù, ÁÖ¿ä ÀÇ·á IT ±â¾÷ Áß ÇϳªÀÎ EnliticÀº º»°ÝÀûÀÎ ºÎǰ, Àåºñ ¹× ¼­ºñ½º¸¦ Á¦°øÇÏ´Â ÀÇ·á ±â¼ú Á¦°ø¾÷üÀÎ MULTI Inc.¿ÍÀÇ »õ·Î¿î Á¦ÈÞ¸¦ ¹ßÇ¥Çß½À´Ï´Ù. ¾ç»ç´Â ¹Ì±¹ Àü¿ªÀÇ ÀÇ·á Á¦°ø¾÷ü¿¡°Ô Enlitic Curie Ç÷§ÆûÀ» Á¦°øÇÏ°í ¹æ»ç¼±°úÀÇ ¾÷¹« È¿À²È­¸¦ Áö¿øÇϱâ À§ÇØ Çù·ÂÇß½À´Ï´Ù. °íǰÁú ȯÀÚ °ü¸®ÀÇ Çʿ伺ÀÌ ³ô¾ÆÁü¿¡ µû¶ó º´¿ø ¾÷°è´Â º¸´Ù È¿À²ÀûÀÎ ¾÷¹«¸¦ ±¸ÃàÇÏ´Â µ¿½Ã¿¡ ´õ ³ªÀº ȯÀÚ Ä¡·á °á°ú¿¡ ±â¿©ÇÏ´Â ¼öÀÍ Àü¸ÁÀ» È®´ëÇÏ´Â µ¥ ÁßÁ¡À» µÎ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¸ñÀûÀ» ´Þ¼ºÇϱâ À§ÇØ Curie|ENDEX ¾ÖÇø®ÄÉÀ̼ÇÀº ¹æ»ç¼± ºÎ¼­ ³»ÀÇ ¿©·¯ »ç¿ëÀÚÀÇ ¿öÅ© Ç÷ο쿡 ¿µÇâÀ» ¹ÌĨ´Ï´Ù.
  • °á°úÀûÀ¸·Î, ¸¹Àº ÀÇ·á ¿µ»ó ¼ÒÇÁÆ®¿þ¾î °ø±Þ¾÷ü´Â ¿©·¯ ³×Æ®¿öÅ©¿¡¼­ ¿µ»ó¿¡ ¾×¼¼½ºÇÒ ¼ö ÀÖ°í Ÿ»ç ¶Ç´Â Áß¾Ó ÁýÁᫎ ÀüÀÚ ÀÇ·á ±â·Ï(HER) ½Ã½ºÅÛ°ú ÅëÇÕÇÒ ¼ö ÀÖ´Â º¥´õ Á߸³ ¾ÆÄ«À̺ê(NVA) ±â¼ú·Î ÀüȯÇϰí ÀÖ½À´Ï´Ù.
  • ¹Ì±¹¾Ï ÇÐȸÀÇ Ãß°è¿¡ ÀÇÇϸé, 2022³â 1¿ù¿¡ ¹Ì±¹¿¡¼­ »õ·Ó°Ô µî·ÏµÇ´Â Æó¾Ï°ú ±â°üÁö¾ÏÀÇ Áõ·Ê ¼ö´Â 2,36,740·ÊÀÔ´Ï´Ù. ÀÌ·¯ÇÑ »ç·Ê ¼ö°¡ °¡Àå ¸¹Àº °ÍÀº Ç÷θ®´Ù ÁÖ·Î ÃßÁ¤µË´Ï´Ù. ¾Ï ȯÀÚ Áõ°¡´Â ÀÇ·á ¿µ»ó ¼ÒÇÁÆ®¿þ¾îÀÇ Çʿ伺À¸·Î À̾îÁý´Ï´Ù.

ÀÇ·á ¿µ»ó ¼ÒÇÁÆ®¿þ¾î »ê¾÷ °³¿ä

ÀÌ ½ÃÀåÀÇ ¾÷ü °£ °æÀïµµ´Â General Healthcare Company(GE), Koninklijke Philips NV, Siemens Healthcare, Canon Medical Systems Corporation, Agfa Gevaert HealthCare µî À¯·Â ±â¾÷ÀÇ Á¸Àç·Î ÀÎÇØ ³ô½À´Ï´Ù. ¾÷°è °¢»ç´Â M&A, ÆÄÆ®³Ê½Ê, ²÷ÀÓ¾ø´Â Çõ½ÅÀ¸·Î °æÀï ¿ìÀ§¸¦ È®º¸Çϱâ À§ÇØ Áö¼ÓÀûÀ¸·Î Á¦Ç° Æ÷Æ®Æú¸®¿À¸¦ °³¹ßÇϰí ÀÖ½À´Ï´Ù.

  • 2022³â 6¿ù - CT, MRI, ÃÊÀ½ÆÄ, ´« Äɾî, Áø´Ü¿ë X¼± ÀåÄ¡, ÀÎÅͺ¥¼Ç X¼± ÀåÄ¡, ¸ð¹ÙÀÏ ¿µ»ó ¼Ö·ç¼Ç, ÇコÄɾî IT ¼Ö·ç¼Ç ¼¼Æ® µî ÀÇ·á ¿µ»ó ¼Ö·ç¼Ç Àü¹ÝÀ» Á¦°øÇϴ ij³í ¸ÞµðÄà ½Ã½ºÅÛÁî ÁÖ½Äȸ»ç´Â 2022³â ºñ¿£³ª¿¡¼­ °³ÃÖµÈ À¯·´ ¹æ»ç¼± ÇÐȸ(European Society of Radiology)¿ÍÀÇ ÆÄÆ®³Ê½ÊÀ» ÅëÇØ ESR ȯÀÚ¿¡°Ô ÀÇ·á ¿µ»ó ¼Ö·ç¼ÇÀ» Á¦°øÇÕ´Ï´Ù.

±âŸ ÇýÅÃ

  • ¿¢¼¿ Çü½Ä ½ÃÀå ¿¹Ãø(ME) ½ÃÆ®
  • 3°³¿ù°£ÀÇ ¾Ö³Î¸®½ºÆ® ¼­Æ÷Æ®

¸ñÂ÷

Á¦1Àå ¼­·Ð

  • Á¶»çÀÇ ÀüÁ¦Á¶°Ç°ú ½ÃÀå Á¤ÀÇ
  • Á¶»ç ¹üÀ§

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå °³¿ä
  • »ê¾÷ ¹ë·ùüÀÎ ºÐ¼®
  • ¾÷°èÀÇ ¸Å·Âµµ - Porter's Five Forces ºÐ¼®
    • ½Å±Ô Âü°¡¾÷üÀÇ À§Çù
    • ±¸¸ÅÀÚÀÇ Çù»ó·Â
    • °ø±Þ±â¾÷ÀÇ Çù»ó·Â
    • ´ëüǰÀÇ À§Çù
    • °æÀï ±â¾÷°£ °æÀï °ü°èÀÇ °­µµ
  • ½ÃÀå¿¡ ´ëÇÑ COVID-19ÀÇ ¿µÇâ Æò°¡

Á¦5Àå ½ÃÀå ¿ªÇÐ

  • ÃËÁø¿äÀÎ
    • ÄÄÇ»ÅÍ Áö¿ø Áø´Ü¹ýÀÇ È®´ë
  • ¾ïÁ¦¿äÀÎ
    • ¼÷·ÃµÈ Àü¹®°¡ ºÎÁ·°ú ³ôÀº ±â±â ¼³Ä¡ ºñ¿ë

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

  • È­»ó À¯Çüº°
    • 2D À̹Ì¡
    • 3D À̹Ì¡
    • 4D À̹Ì¡
  • ¿ëµµº°
    • Ä¡°ú¿ëµµ
    • Á¤Çü¿Ü°ú
    • ½ÉÀ庴 ¿ëµµ
    • »êºÎÀΰú ¿ëµµ
    • À¯¹æ Á¶¿µ
    • ºñ´¢±â ¹× ½ÅÀå ¿ëµµ
    • ±âŸ ¿ëµµ
  • Áö¿ªº°
    • ºÏ¹Ì
      • ¹Ì±¹
      • ij³ª´Ù
    • À¯·´
      • µ¶ÀÏ
      • ÇÁ¶û½º
      • ¿µ±¹
      • ±âŸ À¯·´
    • ¾Æ½Ã¾ÆÅÂÆò¾ç
      • Áß±¹
      • ÀϺ»
      • Àεµ
      • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ¼¼°è ±âŸ Áö¿ª
      • ¶óƾ¾Æ¸Þ¸®Ä«
      • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦7Àå °æÀï ±¸µµ

  • ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • General Healthcare Company(GE)
    • Koninklijke Philips NV
    • Siemens Healthcare
    • Canon Medical Systems Corporation
    • Agfa Gevaert HealthCare
    • Novarad Corporation
    • Carestream Health Inc.
    • Esaote SpA.
    • MIM Software Inc.
    • Fujifilm Holding Company
    • Cerner Corporation
    • Change Healthcare

Á¦8Àå ÅõÀÚ ºÐ¼®

Á¦9Àå ½ÃÀå ±âȸ¿Í ¾ÕÀ¸·ÎÀÇ µ¿Çâ

CSM 25.02.17

The Medical Imaging Software Market size is estimated at USD 8.75 billion in 2025, and is expected to reach USD 12.76 billion by 2030, at a CAGR of 7.84% during the forecast period (2025-2030).

Medical Imaging Software - Market - IMG1

Machine learning and artificial intelligence have attracted the healthcare industry as these innovative analytics strategies have become more accurate and precise.

Key Highlights

  • The need for medical imaging software for advanced treatment for people with arthritis, cancer, etc., demands an advanced version. This advanced image is used to advance patient care and improve operating productivity by empowering doctors and other healthcare professionals by providing more details about patient conditions.
  • An increase in demand for diagnostic imaging software in applications such as dental, Orthopedic, Cardiology, obstetrics and gynecology, Mammography, urology, and neurology, is expected to contribute to the market growth.
  • The increasing use of ultrasonic imaging equipment for earlier diagnosis, particularly chronic disorders, is likely to drive the market's demand. Furthermore, ongoing advancements in imaging technologies, such as Computer-aided Diagnosis (CAD), are expected to boost demand for these systems. The adoption of Artificial Intelligence (AI) in medical imaging has transformed market trends in recent years and is expected to impact future growth positively.
  • The high cost of imaging equipment, combined with the increased implementation and licensing fees of software, is the biggest constraint to market expansion, particularly in countries with poor reimbursement scenarios. For example, most healthcare facilities in developing nations, such as hospitals and diagnostic centers, have costs.
  • During the COVID-19 pandemic, various AI, machine learning, and deep learning technologies were applied in medical image processing, which will drive market expansion further. Because of the increasing demand for efficient solutions for better patient outcomes, diagnostic and research institutes are expected to emerge as significant end users of image analysis solutions. Due to the technological advancements in medical applications, the market is increasing after the pandemic.

Medical Imaging Software Market Trends

Cardiology Applications Segment Holds Major Market Share

  • As the frequency of chronic diseases related to the heart is increasing globally, the demand for medical imaging software is increasing. With such rising demand, prominent market players are focusing on R&D and new product launches, as well as joint ventures and acquisitions, to develop their businesses.
  • For instance, in March 2022, Philips announced Health Suite Interoperability, a fully integrated cloud-enabled Health IT platform designed to address the different workflow demands of the imaging industry.
  • Medical image software has been found to improve analysis speed and accuracy. Key players around the globe are integrating emerging technologies like AI and Cloud computing to introduce new medical imaging software applications. For instance, Arterys, located in San Francisco, combines deep learning AI algorithms with cloud computing. Arterys designed for cardiac MRIs to assist in identifying abnormal lesions in these areas.
  • In February 2022, Cleery launched Cleerly 2.2.0, a new software version that tracks heart disease based on the quantity and kind of atherosclerosis. Such market innovations and new product releases contribute to expanding the Medical Imaging Software Market Size.
  • In Cardiac problems like heart transplantation, medical imaging software is used to know the volumetric and functional data analysis. According to Scandiatransplant, the number of heart transplant recipients in the Nordic countries in 2021 Sweden had the most significant number of transplanted heart patients, with 66 individuals transplanted a new heart. Denmark had the second-highest number of transplants, with 24 patients.

North America is Expected to Register the Largest Market

  • North America is expected to be the largest market for medical imaging software globally. The region has a considerably high level of investments in medical infrastructure, especially in countries like the United States, Mexico, and Canada. This scenario, coupled with the increasing multitude of hardware in the region, is expected to boost the demand for medical imaging software.
  • The expansion can be attributed to the availability of well-established healthcare institutions equipped with modern diagnostic equipment and favorable government measures to boost the use of healthcare IT in this region. Furthermore, rising R&D investments and the presence of significant market competitors are fueling regional market expansion.
  • In October 2022, Enlitic, one of the leading healthcare IT firms, announced a new partnership with MULTI Inc., a healthcare technology provider of authentic parts, equipment, and services. The two organizations collaborated to provide the Enlitic Curie platform to healthcare providers across the United States to assist radiology departments in driving operational efficiencies. As the need for high-quality patient care grows, hospital leaders focus on building more efficient operations while expanding revenue prospects that contribute to better patient outcomes. To achieve these aims, the Curie|ENDEX application impacts the workflows of several users within the radiology department.
  • As a result, many medical imaging software vendors are moving towards vendor-neutral archive (VNA) technologies that enable access to images form several networks and the ability to integrate them with third-party or centralized Electronic Health Record (HER) systems.
  • According to the American Cancer Society estimation in January 2022, the number of new lung and bronchus cancer cases registered in the United States is 2,36,740. The highest number of these cases is estimated to be in Florida. The increase in cancer patients necessitates the use of medical imaging software.

Medical Imaging Software Industry Overview

The competitive rivalry in this market is high because of dominant players like General Healthcare Company (GE), Koninklijke Philips N.V., Siemens Healthcare, Canon Medical Systems Corporation, and Agfa Gevaert HealthCare, among others. The industry players constantly develop their product portfolios to gain competitive advantages with mergers and acquisitions, partnerships, and constant innovations.

  • June 2022 - Canon Medical Systems Corporation, which provides a full range of medical imaging solutions such as CT, MRI, Ultrasound, Eye Care, Diagnostic and Interventional X-Ray equipment, Mobile Imaging Solutions, and a full suite of Healthcare IT solutions, has expanded its partnership with the European Society of Radiology for the 2022 onsite edition in Vienna. Through the partnership, Canon Medical offers its medical imaging solutions to ESR patients.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET INSIGHTS

  • 4.1 Market Overview
  • 4.2 Industry Value Chain Analysis
  • 4.3 Industry Attractiveness - Porter's Five Forces Analysis
    • 4.3.1 Threat of New Entrants
    • 4.3.2 Bargaining Power of Buyers
    • 4.3.3 Bargaining Power of Suppliers
    • 4.3.4 Threat of Substitute Products
    • 4.3.5 Intensity of Competitive Rivalry
  • 4.4 Assessment of Impact of COVID-19 on the Market

5 MARKET DYNAMICS

  • 5.1 Market Drivers
    • 5.1.1 Growing Application of Computer-Aided Diagnostic Methods
  • 5.2 Market Restraints
    • 5.2.1 Dearth of Skilled Professionals and High Set-up Cost of the Equipment

6 MARKET SEGMENTATION

  • 6.1 By Imaging Type
    • 6.1.1 2D Imaging
    • 6.1.2 3D Imaging
    • 6.1.3 4D Imaging
  • 6.2 By Application
    • 6.2.1 Dental Applications
    • 6.2.2 Orthopaedic Applications
    • 6.2.3 Cardiology Applications
    • 6.2.4 Obstetrics and Gynaecology Applications
    • 6.2.5 Mammography Applications
    • 6.2.6 Urology and Nephrology Applications
    • 6.2.7 Other Applications
  • 6.3 Geography
    • 6.3.1 North America
      • 6.3.1.1 United States
      • 6.3.1.2 Canada
    • 6.3.2 Europe
      • 6.3.2.1 Germany
      • 6.3.2.2 France
      • 6.3.2.3 United Kingdom
      • 6.3.2.4 Rest of Europe
    • 6.3.3 Asia-Pacific
      • 6.3.3.1 China
      • 6.3.3.2 Japan
      • 6.3.3.3 India
      • 6.3.3.4 Rest of Asia-Pacific
    • 6.3.4 Rest of the World
      • 6.3.4.1 Latin America
      • 6.3.4.2 Middle-East & Africa

7 COMPETITIVE LANDSCAPE

  • 7.1 Company Profiles
    • 7.1.1 General Healthcare Company (GE)
    • 7.1.2 Koninklijke Philips N.V.
    • 7.1.3 Siemens Healthcare
    • 7.1.4 Canon Medical Systems Corporation
    • 7.1.5 Agfa Gevaert HealthCare
    • 7.1.6 Novarad Corporation
    • 7.1.7 Carestream Health Inc.
    • 7.1.8 Esaote SpA.
    • 7.1.9 MIM Software Inc.
    • 7.1.10 Fujifilm Holding Company
    • 7.1.11 Cerner Corporation
    • 7.1.12 Change Healthcare

8 INVESTMENT ANALYSIS

9 MARKET OPPORTUNITIES AND FUTURE TRENDS

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦